Global Cell Therapy Market Market

Cell Therapy Market Comprehensive Study by Application (Musculoskeletal, Malignancies, Cardiovascular, Dermatology and Wounds, Other), Type (Autologous, Allogeneic), End User (Hospitals, Homecare, Specialty Clinics), Therapy (Mesenchymal Stem Cell Therapy, Fibroblast Cell Therapy, Hematopoietic Stem Cell Therapy, Other) Players and Region - Global Market Outlook to 2028

Cell Therapy Market Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Cell Therapy Market Market Overview:
Cell therapy refers to the transfer of autologous or allogeneic cellular material into a patient for medical purposes. The most common type of cell therapy is blood transfusion, the transfusion of red blood cells, white blood cells, and platelets from a donor. Potential applications of cell therapies include treating cancers, autoimmune diseases, urinary problems, and infectious diseases, rebuilding damaged cartilage in joints, repairing spinal cord injuries, improving a weakened immune system, and helping patients with neurological disorders.

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Historical Period2018-2022
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Influencing Trend:
Increasing Cell Therapy based research and Development

Market Growth Drivers:
Growing Number of Cancer Patients and Incidences across the Globe

Challenges:
Need For Continuous Improvement in Treatments Offering, Weak Health System and Lack of Infrastructure and Lack of Awareness and Other Debunking about Cell Therapy

Restraints:
Global Shortage of Cell Donors and High-Cost Associates with Cell Therapy

Opportunities:
Increasing Demand for Innovative Technology Such as Nucleic Acid Format and Viral Biosynthesis Methods for Nano Scale Analytics, Rising Demand for Product Optimization and Growing Awareness about Machine Learning and Artificial Intelligence to Classify Patients Improvements using Cell Therapy

Competitive Landscape:
The cell Therapy Market is a fragmented market due to the presence of a large number of established competitors. The key players are highly focused on developing and innovating new strategies to maintain their market position and customer base. The companies are also planning strategic activities like partnerships, collaboration, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge.
Some of the key players profiled in the report are Novartis AG (Switzerland), Bluebird Bio (United States), Verticel (United States), Bristol Myers Squibb (United States), Amgen (United States), Gilead Sciences Inc. (United States), NuVasive (United States), Celyad Oncology (Belgium), Allogene Therapeutics (United States) and Abeona Cell Therapeutics (United States). Considering Market by Type , the sub-segment i.e. Autologous will boost the Cell Therapy Market market. Considering Market by End User, the sub-segment i.e. Hospitals will boost the Cell Therapy Market market. Considering Market by Therapy , the sub-segment i.e. Mesenchymal Stem Cell Therapy will boost the Cell Therapy Market market.

Latest Market Insights:
In February 2023, Globus Medical, a leading musculoskeletal solution company, and NUVASIVE, a leader in spinal technology innovation, entered into a definitive agreement to merge under a Jeonju transaction. This transaction unites two well-known technology companies in the musculoskeletal industry with a shared vision focused on innovation that relentlessly pursues unmet clinical needs to improve patient care.

In March 2020, Novartis entered into an initial agreement with Carisma Therapeutics, a biopharmaceutical pioneer in engineered macrophage-based therapeutics, to manufacture an HER 2-targeted CAR-M cell therapy, which was tested in an initial trial to treat solid tumors. Novartis' Global Biotech Cooperation’s division is committed to bringing CAR-M cell therapy to patients by collaborating with Carisma Therapeutics to provide proven, state-of-the-art cell and gene production capabilities.

What Can be Explored with the Cell Therapy Market Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Cell Therapy Market Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Cell Therapy Market
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Cell Therapy Market market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Cell Therapy Market market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Health Care Industries, Government Bodies and R&D Specialist.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Application
  • Musculoskeletal
  • Malignancies
  • Cardiovascular
  • Dermatology and Wounds
  • Other
By Type
  • Autologous
  • Allogeneic

By End User
  • Hospitals
  • Homecare
  • Specialty Clinics

By Therapy
  • Mesenchymal Stem Cell Therapy
  • Fibroblast Cell Therapy
  • Hematopoietic Stem Cell Therapy
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Number of Cancer Patients and Incidences across the Globe
    • 3.3. Market Challenges
      • 3.3.1. Need For Continuous Improvement in Treatments Offering
      • 3.3.2. Weak Health System and Lack of Infrastructure
      • 3.3.3. Lack of Awareness and Other Debunking about Cell Therapy
    • 3.4. Market Trends
      • 3.4.1. Increasing Cell Therapy based research and Development
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Cell Therapy Market, by Application, Type , End User, Therapy and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Cell Therapy Market (Value)
      • 5.2.1. Global Cell Therapy Market by: Application (Value)
        • 5.2.1.1. Musculoskeletal
        • 5.2.1.2. Malignancies
        • 5.2.1.3. Cardiovascular
        • 5.2.1.4. Dermatology and Wounds
        • 5.2.1.5. Other
      • 5.2.2. Global Cell Therapy Market by: End User (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Homecare
        • 5.2.2.3. Specialty Clinics
      • 5.2.3. Global Cell Therapy Market Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Cell Therapy Market: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Novartis AG (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bluebird Bio (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Verticel (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Bristol Myers Squibb (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Amgen (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Gilead Sciences Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. NuVasive (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Celyad Oncology (Belgium)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Allogene Therapeutics (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Abeona Cell Therapeutics (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Cell Therapy Market Sale, by Application, Type , End User, Therapy and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Cell Therapy Market (Value)
      • 7.2.1. Global Cell Therapy Market by: Application (Value)
        • 7.2.1.1. Musculoskeletal
        • 7.2.1.2. Malignancies
        • 7.2.1.3. Cardiovascular
        • 7.2.1.4. Dermatology and Wounds
        • 7.2.1.5. Other
      • 7.2.2. Global Cell Therapy Market by: End User (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Homecare
        • 7.2.2.3. Specialty Clinics
      • 7.2.3. Global Cell Therapy Market Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Cell Therapy Market: by Application(USD Million)
  • Table 2. Cell Therapy Market Musculoskeletal , by Region USD Million (2017-2022)
  • Table 3. Cell Therapy Market Malignancies , by Region USD Million (2017-2022)
  • Table 4. Cell Therapy Market Cardiovascular , by Region USD Million (2017-2022)
  • Table 5. Cell Therapy Market Dermatology and Wounds , by Region USD Million (2017-2022)
  • Table 6. Cell Therapy Market Other , by Region USD Million (2017-2022)
  • Table 7. Cell Therapy Market: by End User(USD Million)
  • Table 8. Cell Therapy Market Hospitals , by Region USD Million (2017-2022)
  • Table 9. Cell Therapy Market Homecare , by Region USD Million (2017-2022)
  • Table 10. Cell Therapy Market Specialty Clinics , by Region USD Million (2017-2022)
  • Table 11. South America Cell Therapy Market, by Country USD Million (2017-2022)
  • Table 12. South America Cell Therapy Market, by Application USD Million (2017-2022)
  • Table 13. South America Cell Therapy Market, by Type USD Million (2017-2022)
  • Table 14. South America Cell Therapy Market, by End User USD Million (2017-2022)
  • Table 15. South America Cell Therapy Market, by Therapy USD Million (2017-2022)
  • Table 16. Brazil Cell Therapy Market, by Application USD Million (2017-2022)
  • Table 17. Brazil Cell Therapy Market, by Type USD Million (2017-2022)
  • Table 18. Brazil Cell Therapy Market, by End User USD Million (2017-2022)
  • Table 19. Brazil Cell Therapy Market, by Therapy USD Million (2017-2022)
  • Table 20. Argentina Cell Therapy Market, by Application USD Million (2017-2022)
  • Table 21. Argentina Cell Therapy Market, by Type USD Million (2017-2022)
  • Table 22. Argentina Cell Therapy Market, by End User USD Million (2017-2022)
  • Table 23. Argentina Cell Therapy Market, by Therapy USD Million (2017-2022)
  • Table 24. Rest of South America Cell Therapy Market, by Application USD Million (2017-2022)
  • Table 25. Rest of South America Cell Therapy Market, by Type USD Million (2017-2022)
  • Table 26. Rest of South America Cell Therapy Market, by End User USD Million (2017-2022)
  • Table 27. Rest of South America Cell Therapy Market, by Therapy USD Million (2017-2022)
  • Table 28. Asia Pacific Cell Therapy Market, by Country USD Million (2017-2022)
  • Table 29. Asia Pacific Cell Therapy Market, by Application USD Million (2017-2022)
  • Table 30. Asia Pacific Cell Therapy Market, by Type USD Million (2017-2022)
  • Table 31. Asia Pacific Cell Therapy Market, by End User USD Million (2017-2022)
  • Table 32. Asia Pacific Cell Therapy Market, by Therapy USD Million (2017-2022)
  • Table 33. China Cell Therapy Market, by Application USD Million (2017-2022)
  • Table 34. China Cell Therapy Market, by Type USD Million (2017-2022)
  • Table 35. China Cell Therapy Market, by End User USD Million (2017-2022)
  • Table 36. China Cell Therapy Market, by Therapy USD Million (2017-2022)
  • Table 37. Japan Cell Therapy Market, by Application USD Million (2017-2022)
  • Table 38. Japan Cell Therapy Market, by Type USD Million (2017-2022)
  • Table 39. Japan Cell Therapy Market, by End User USD Million (2017-2022)
  • Table 40. Japan Cell Therapy Market, by Therapy USD Million (2017-2022)
  • Table 41. India Cell Therapy Market, by Application USD Million (2017-2022)
  • Table 42. India Cell Therapy Market, by Type USD Million (2017-2022)
  • Table 43. India Cell Therapy Market, by End User USD Million (2017-2022)
  • Table 44. India Cell Therapy Market, by Therapy USD Million (2017-2022)
  • Table 45. South Korea Cell Therapy Market, by Application USD Million (2017-2022)
  • Table 46. South Korea Cell Therapy Market, by Type USD Million (2017-2022)
  • Table 47. South Korea Cell Therapy Market, by End User USD Million (2017-2022)
  • Table 48. South Korea Cell Therapy Market, by Therapy USD Million (2017-2022)
  • Table 49. Taiwan Cell Therapy Market, by Application USD Million (2017-2022)
  • Table 50. Taiwan Cell Therapy Market, by Type USD Million (2017-2022)
  • Table 51. Taiwan Cell Therapy Market, by End User USD Million (2017-2022)
  • Table 52. Taiwan Cell Therapy Market, by Therapy USD Million (2017-2022)
  • Table 53. Australia Cell Therapy Market, by Application USD Million (2017-2022)
  • Table 54. Australia Cell Therapy Market, by Type USD Million (2017-2022)
  • Table 55. Australia Cell Therapy Market, by End User USD Million (2017-2022)
  • Table 56. Australia Cell Therapy Market, by Therapy USD Million (2017-2022)
  • Table 57. Rest of Asia-Pacific Cell Therapy Market, by Application USD Million (2017-2022)
  • Table 58. Rest of Asia-Pacific Cell Therapy Market, by Type USD Million (2017-2022)
  • Table 59. Rest of Asia-Pacific Cell Therapy Market, by End User USD Million (2017-2022)
  • Table 60. Rest of Asia-Pacific Cell Therapy Market, by Therapy USD Million (2017-2022)
  • Table 61. Europe Cell Therapy Market, by Country USD Million (2017-2022)
  • Table 62. Europe Cell Therapy Market, by Application USD Million (2017-2022)
  • Table 63. Europe Cell Therapy Market, by Type USD Million (2017-2022)
  • Table 64. Europe Cell Therapy Market, by End User USD Million (2017-2022)
  • Table 65. Europe Cell Therapy Market, by Therapy USD Million (2017-2022)
  • Table 66. Germany Cell Therapy Market, by Application USD Million (2017-2022)
  • Table 67. Germany Cell Therapy Market, by Type USD Million (2017-2022)
  • Table 68. Germany Cell Therapy Market, by End User USD Million (2017-2022)
  • Table 69. Germany Cell Therapy Market, by Therapy USD Million (2017-2022)
  • Table 70. France Cell Therapy Market, by Application USD Million (2017-2022)
  • Table 71. France Cell Therapy Market, by Type USD Million (2017-2022)
  • Table 72. France Cell Therapy Market, by End User USD Million (2017-2022)
  • Table 73. France Cell Therapy Market, by Therapy USD Million (2017-2022)
  • Table 74. Italy Cell Therapy Market, by Application USD Million (2017-2022)
  • Table 75. Italy Cell Therapy Market, by Type USD Million (2017-2022)
  • Table 76. Italy Cell Therapy Market, by End User USD Million (2017-2022)
  • Table 77. Italy Cell Therapy Market, by Therapy USD Million (2017-2022)
  • Table 78. United Kingdom Cell Therapy Market, by Application USD Million (2017-2022)
  • Table 79. United Kingdom Cell Therapy Market, by Type USD Million (2017-2022)
  • Table 80. United Kingdom Cell Therapy Market, by End User USD Million (2017-2022)
  • Table 81. United Kingdom Cell Therapy Market, by Therapy USD Million (2017-2022)
  • Table 82. Netherlands Cell Therapy Market, by Application USD Million (2017-2022)
  • Table 83. Netherlands Cell Therapy Market, by Type USD Million (2017-2022)
  • Table 84. Netherlands Cell Therapy Market, by End User USD Million (2017-2022)
  • Table 85. Netherlands Cell Therapy Market, by Therapy USD Million (2017-2022)
  • Table 86. Rest of Europe Cell Therapy Market, by Application USD Million (2017-2022)
  • Table 87. Rest of Europe Cell Therapy Market, by Type USD Million (2017-2022)
  • Table 88. Rest of Europe Cell Therapy Market, by End User USD Million (2017-2022)
  • Table 89. Rest of Europe Cell Therapy Market, by Therapy USD Million (2017-2022)
  • Table 90. MEA Cell Therapy Market, by Country USD Million (2017-2022)
  • Table 91. MEA Cell Therapy Market, by Application USD Million (2017-2022)
  • Table 92. MEA Cell Therapy Market, by Type USD Million (2017-2022)
  • Table 93. MEA Cell Therapy Market, by End User USD Million (2017-2022)
  • Table 94. MEA Cell Therapy Market, by Therapy USD Million (2017-2022)
  • Table 95. Middle East Cell Therapy Market, by Application USD Million (2017-2022)
  • Table 96. Middle East Cell Therapy Market, by Type USD Million (2017-2022)
  • Table 97. Middle East Cell Therapy Market, by End User USD Million (2017-2022)
  • Table 98. Middle East Cell Therapy Market, by Therapy USD Million (2017-2022)
  • Table 99. Africa Cell Therapy Market, by Application USD Million (2017-2022)
  • Table 100. Africa Cell Therapy Market, by Type USD Million (2017-2022)
  • Table 101. Africa Cell Therapy Market, by End User USD Million (2017-2022)
  • Table 102. Africa Cell Therapy Market, by Therapy USD Million (2017-2022)
  • Table 103. North America Cell Therapy Market, by Country USD Million (2017-2022)
  • Table 104. North America Cell Therapy Market, by Application USD Million (2017-2022)
  • Table 105. North America Cell Therapy Market, by Type USD Million (2017-2022)
  • Table 106. North America Cell Therapy Market, by End User USD Million (2017-2022)
  • Table 107. North America Cell Therapy Market, by Therapy USD Million (2017-2022)
  • Table 108. United States Cell Therapy Market, by Application USD Million (2017-2022)
  • Table 109. United States Cell Therapy Market, by Type USD Million (2017-2022)
  • Table 110. United States Cell Therapy Market, by End User USD Million (2017-2022)
  • Table 111. United States Cell Therapy Market, by Therapy USD Million (2017-2022)
  • Table 112. Canada Cell Therapy Market, by Application USD Million (2017-2022)
  • Table 113. Canada Cell Therapy Market, by Type USD Million (2017-2022)
  • Table 114. Canada Cell Therapy Market, by End User USD Million (2017-2022)
  • Table 115. Canada Cell Therapy Market, by Therapy USD Million (2017-2022)
  • Table 116. Mexico Cell Therapy Market, by Application USD Million (2017-2022)
  • Table 117. Mexico Cell Therapy Market, by Type USD Million (2017-2022)
  • Table 118. Mexico Cell Therapy Market, by End User USD Million (2017-2022)
  • Table 119. Mexico Cell Therapy Market, by Therapy USD Million (2017-2022)
  • Table 120. Company Basic Information, Sales Area and Its Competitors
  • Table 121. Company Basic Information, Sales Area and Its Competitors
  • Table 122. Company Basic Information, Sales Area and Its Competitors
  • Table 123. Company Basic Information, Sales Area and Its Competitors
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Cell Therapy Market: by Application(USD Million)
  • Table 131. Cell Therapy Market Musculoskeletal , by Region USD Million (2023-2028)
  • Table 132. Cell Therapy Market Malignancies , by Region USD Million (2023-2028)
  • Table 133. Cell Therapy Market Cardiovascular , by Region USD Million (2023-2028)
  • Table 134. Cell Therapy Market Dermatology and Wounds , by Region USD Million (2023-2028)
  • Table 135. Cell Therapy Market Other , by Region USD Million (2023-2028)
  • Table 136. Cell Therapy Market: by End User(USD Million)
  • Table 137. Cell Therapy Market Hospitals , by Region USD Million (2023-2028)
  • Table 138. Cell Therapy Market Homecare , by Region USD Million (2023-2028)
  • Table 139. Cell Therapy Market Specialty Clinics , by Region USD Million (2023-2028)
  • Table 140. South America Cell Therapy Market, by Country USD Million (2023-2028)
  • Table 141. South America Cell Therapy Market, by Application USD Million (2023-2028)
  • Table 142. South America Cell Therapy Market, by Type USD Million (2023-2028)
  • Table 143. South America Cell Therapy Market, by End User USD Million (2023-2028)
  • Table 144. South America Cell Therapy Market, by Therapy USD Million (2023-2028)
  • Table 145. Brazil Cell Therapy Market, by Application USD Million (2023-2028)
  • Table 146. Brazil Cell Therapy Market, by Type USD Million (2023-2028)
  • Table 147. Brazil Cell Therapy Market, by End User USD Million (2023-2028)
  • Table 148. Brazil Cell Therapy Market, by Therapy USD Million (2023-2028)
  • Table 149. Argentina Cell Therapy Market, by Application USD Million (2023-2028)
  • Table 150. Argentina Cell Therapy Market, by Type USD Million (2023-2028)
  • Table 151. Argentina Cell Therapy Market, by End User USD Million (2023-2028)
  • Table 152. Argentina Cell Therapy Market, by Therapy USD Million (2023-2028)
  • Table 153. Rest of South America Cell Therapy Market, by Application USD Million (2023-2028)
  • Table 154. Rest of South America Cell Therapy Market, by Type USD Million (2023-2028)
  • Table 155. Rest of South America Cell Therapy Market, by End User USD Million (2023-2028)
  • Table 156. Rest of South America Cell Therapy Market, by Therapy USD Million (2023-2028)
  • Table 157. Asia Pacific Cell Therapy Market, by Country USD Million (2023-2028)
  • Table 158. Asia Pacific Cell Therapy Market, by Application USD Million (2023-2028)
  • Table 159. Asia Pacific Cell Therapy Market, by Type USD Million (2023-2028)
  • Table 160. Asia Pacific Cell Therapy Market, by End User USD Million (2023-2028)
  • Table 161. Asia Pacific Cell Therapy Market, by Therapy USD Million (2023-2028)
  • Table 162. China Cell Therapy Market, by Application USD Million (2023-2028)
  • Table 163. China Cell Therapy Market, by Type USD Million (2023-2028)
  • Table 164. China Cell Therapy Market, by End User USD Million (2023-2028)
  • Table 165. China Cell Therapy Market, by Therapy USD Million (2023-2028)
  • Table 166. Japan Cell Therapy Market, by Application USD Million (2023-2028)
  • Table 167. Japan Cell Therapy Market, by Type USD Million (2023-2028)
  • Table 168. Japan Cell Therapy Market, by End User USD Million (2023-2028)
  • Table 169. Japan Cell Therapy Market, by Therapy USD Million (2023-2028)
  • Table 170. India Cell Therapy Market, by Application USD Million (2023-2028)
  • Table 171. India Cell Therapy Market, by Type USD Million (2023-2028)
  • Table 172. India Cell Therapy Market, by End User USD Million (2023-2028)
  • Table 173. India Cell Therapy Market, by Therapy USD Million (2023-2028)
  • Table 174. South Korea Cell Therapy Market, by Application USD Million (2023-2028)
  • Table 175. South Korea Cell Therapy Market, by Type USD Million (2023-2028)
  • Table 176. South Korea Cell Therapy Market, by End User USD Million (2023-2028)
  • Table 177. South Korea Cell Therapy Market, by Therapy USD Million (2023-2028)
  • Table 178. Taiwan Cell Therapy Market, by Application USD Million (2023-2028)
  • Table 179. Taiwan Cell Therapy Market, by Type USD Million (2023-2028)
  • Table 180. Taiwan Cell Therapy Market, by End User USD Million (2023-2028)
  • Table 181. Taiwan Cell Therapy Market, by Therapy USD Million (2023-2028)
  • Table 182. Australia Cell Therapy Market, by Application USD Million (2023-2028)
  • Table 183. Australia Cell Therapy Market, by Type USD Million (2023-2028)
  • Table 184. Australia Cell Therapy Market, by End User USD Million (2023-2028)
  • Table 185. Australia Cell Therapy Market, by Therapy USD Million (2023-2028)
  • Table 186. Rest of Asia-Pacific Cell Therapy Market, by Application USD Million (2023-2028)
  • Table 187. Rest of Asia-Pacific Cell Therapy Market, by Type USD Million (2023-2028)
  • Table 188. Rest of Asia-Pacific Cell Therapy Market, by End User USD Million (2023-2028)
  • Table 189. Rest of Asia-Pacific Cell Therapy Market, by Therapy USD Million (2023-2028)
  • Table 190. Europe Cell Therapy Market, by Country USD Million (2023-2028)
  • Table 191. Europe Cell Therapy Market, by Application USD Million (2023-2028)
  • Table 192. Europe Cell Therapy Market, by Type USD Million (2023-2028)
  • Table 193. Europe Cell Therapy Market, by End User USD Million (2023-2028)
  • Table 194. Europe Cell Therapy Market, by Therapy USD Million (2023-2028)
  • Table 195. Germany Cell Therapy Market, by Application USD Million (2023-2028)
  • Table 196. Germany Cell Therapy Market, by Type USD Million (2023-2028)
  • Table 197. Germany Cell Therapy Market, by End User USD Million (2023-2028)
  • Table 198. Germany Cell Therapy Market, by Therapy USD Million (2023-2028)
  • Table 199. France Cell Therapy Market, by Application USD Million (2023-2028)
  • Table 200. France Cell Therapy Market, by Type USD Million (2023-2028)
  • Table 201. France Cell Therapy Market, by End User USD Million (2023-2028)
  • Table 202. France Cell Therapy Market, by Therapy USD Million (2023-2028)
  • Table 203. Italy Cell Therapy Market, by Application USD Million (2023-2028)
  • Table 204. Italy Cell Therapy Market, by Type USD Million (2023-2028)
  • Table 205. Italy Cell Therapy Market, by End User USD Million (2023-2028)
  • Table 206. Italy Cell Therapy Market, by Therapy USD Million (2023-2028)
  • Table 207. United Kingdom Cell Therapy Market, by Application USD Million (2023-2028)
  • Table 208. United Kingdom Cell Therapy Market, by Type USD Million (2023-2028)
  • Table 209. United Kingdom Cell Therapy Market, by End User USD Million (2023-2028)
  • Table 210. United Kingdom Cell Therapy Market, by Therapy USD Million (2023-2028)
  • Table 211. Netherlands Cell Therapy Market, by Application USD Million (2023-2028)
  • Table 212. Netherlands Cell Therapy Market, by Type USD Million (2023-2028)
  • Table 213. Netherlands Cell Therapy Market, by End User USD Million (2023-2028)
  • Table 214. Netherlands Cell Therapy Market, by Therapy USD Million (2023-2028)
  • Table 215. Rest of Europe Cell Therapy Market, by Application USD Million (2023-2028)
  • Table 216. Rest of Europe Cell Therapy Market, by Type USD Million (2023-2028)
  • Table 217. Rest of Europe Cell Therapy Market, by End User USD Million (2023-2028)
  • Table 218. Rest of Europe Cell Therapy Market, by Therapy USD Million (2023-2028)
  • Table 219. MEA Cell Therapy Market, by Country USD Million (2023-2028)
  • Table 220. MEA Cell Therapy Market, by Application USD Million (2023-2028)
  • Table 221. MEA Cell Therapy Market, by Type USD Million (2023-2028)
  • Table 222. MEA Cell Therapy Market, by End User USD Million (2023-2028)
  • Table 223. MEA Cell Therapy Market, by Therapy USD Million (2023-2028)
  • Table 224. Middle East Cell Therapy Market, by Application USD Million (2023-2028)
  • Table 225. Middle East Cell Therapy Market, by Type USD Million (2023-2028)
  • Table 226. Middle East Cell Therapy Market, by End User USD Million (2023-2028)
  • Table 227. Middle East Cell Therapy Market, by Therapy USD Million (2023-2028)
  • Table 228. Africa Cell Therapy Market, by Application USD Million (2023-2028)
  • Table 229. Africa Cell Therapy Market, by Type USD Million (2023-2028)
  • Table 230. Africa Cell Therapy Market, by End User USD Million (2023-2028)
  • Table 231. Africa Cell Therapy Market, by Therapy USD Million (2023-2028)
  • Table 232. North America Cell Therapy Market, by Country USD Million (2023-2028)
  • Table 233. North America Cell Therapy Market, by Application USD Million (2023-2028)
  • Table 234. North America Cell Therapy Market, by Type USD Million (2023-2028)
  • Table 235. North America Cell Therapy Market, by End User USD Million (2023-2028)
  • Table 236. North America Cell Therapy Market, by Therapy USD Million (2023-2028)
  • Table 237. United States Cell Therapy Market, by Application USD Million (2023-2028)
  • Table 238. United States Cell Therapy Market, by Type USD Million (2023-2028)
  • Table 239. United States Cell Therapy Market, by End User USD Million (2023-2028)
  • Table 240. United States Cell Therapy Market, by Therapy USD Million (2023-2028)
  • Table 241. Canada Cell Therapy Market, by Application USD Million (2023-2028)
  • Table 242. Canada Cell Therapy Market, by Type USD Million (2023-2028)
  • Table 243. Canada Cell Therapy Market, by End User USD Million (2023-2028)
  • Table 244. Canada Cell Therapy Market, by Therapy USD Million (2023-2028)
  • Table 245. Mexico Cell Therapy Market, by Application USD Million (2023-2028)
  • Table 246. Mexico Cell Therapy Market, by Type USD Million (2023-2028)
  • Table 247. Mexico Cell Therapy Market, by End User USD Million (2023-2028)
  • Table 248. Mexico Cell Therapy Market, by Therapy USD Million (2023-2028)
  • Table 249. Research Programs/Design for This Report
  • Table 250. Key Data Information from Secondary Sources
  • Table 251. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Cell Therapy Market: by Application USD Million (2017-2022)
  • Figure 5. Global Cell Therapy Market: by End User USD Million (2017-2022)
  • Figure 6. South America Cell Therapy Market Share (%), by Country
  • Figure 7. Asia Pacific Cell Therapy Market Share (%), by Country
  • Figure 8. Europe Cell Therapy Market Share (%), by Country
  • Figure 9. MEA Cell Therapy Market Share (%), by Country
  • Figure 10. North America Cell Therapy Market Share (%), by Country
  • Figure 11. Global Cell Therapy Market share by Players 2022 (%)
  • Figure 12. Global Cell Therapy Market share by Players (Top 3) 2022(%)
  • Figure 13. Global Cell Therapy Market share by Players (Top 5) 2022(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 16. Novartis AG (Switzerland) Revenue: by Geography 2022
  • Figure 17. Bluebird Bio (United States) Revenue, Net Income and Gross profit
  • Figure 18. Bluebird Bio (United States) Revenue: by Geography 2022
  • Figure 19. Verticel (United States) Revenue, Net Income and Gross profit
  • Figure 20. Verticel (United States) Revenue: by Geography 2022
  • Figure 21. Bristol Myers Squibb (United States) Revenue, Net Income and Gross profit
  • Figure 22. Bristol Myers Squibb (United States) Revenue: by Geography 2022
  • Figure 23. Amgen (United States) Revenue, Net Income and Gross profit
  • Figure 24. Amgen (United States) Revenue: by Geography 2022
  • Figure 25. Gilead Sciences Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Gilead Sciences Inc. (United States) Revenue: by Geography 2022
  • Figure 27. NuVasive (United States) Revenue, Net Income and Gross profit
  • Figure 28. NuVasive (United States) Revenue: by Geography 2022
  • Figure 29. Celyad Oncology (Belgium) Revenue, Net Income and Gross profit
  • Figure 30. Celyad Oncology (Belgium) Revenue: by Geography 2022
  • Figure 31. Allogene Therapeutics (United States) Revenue, Net Income and Gross profit
  • Figure 32. Allogene Therapeutics (United States) Revenue: by Geography 2022
  • Figure 33. Abeona Cell Therapeutics (United States) Revenue, Net Income and Gross profit
  • Figure 34. Abeona Cell Therapeutics (United States) Revenue: by Geography 2022
  • Figure 35. Global Cell Therapy Market: by Application USD Million (2023-2028)
  • Figure 36. Global Cell Therapy Market: by End User USD Million (2023-2028)
  • Figure 37. South America Cell Therapy Market Share (%), by Country
  • Figure 38. Asia Pacific Cell Therapy Market Share (%), by Country
  • Figure 39. Europe Cell Therapy Market Share (%), by Country
  • Figure 40. MEA Cell Therapy Market Share (%), by Country
  • Figure 41. North America Cell Therapy Market Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Novartis AG (Switzerland)
  • Bluebird Bio (United States)
  • Verticel (United States)
  • Bristol Myers Squibb (United States)
  • Amgen (United States)
  • Gilead Sciences Inc. (United States)
  • NuVasive (United States)
  • Celyad Oncology (Belgium)
  • Allogene Therapeutics (United States)
  • Abeona Cell Therapeutics (United States)
Select User Access Type

Key Highlights of Report


Jun 2023 246 Pages 61 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Cell Therapy Market Market Quantitative research analysis
Global Cell Therapy Market Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Cell Therapy Market market are Novartis AG (Switzerland), Bluebird Bio (United States), Verticel (United States), Bristol Myers Squibb (United States), Amgen (United States), Gilead Sciences Inc. (United States), NuVasive (United States), Celyad Oncology (Belgium), Allogene Therapeutics (United States) and Abeona Cell Therapeutics (United States), to name a few.
"Increasing Cell Therapy based research and Development" is seen as one of major influencing trends for Cell Therapy Market Market during projected period 2022-2028.

Know More About Global Cell Therapy Market Market Report?

Have a Query? Click Here

Other Related Reports

Big Data in the Healthcare & Pharmaceutical Industry Comprehensive Study by Application (Financial Analytics, Clinical Data Analytics, Operational Analytics, Population Health Analytics), Deployment ...
$ 3800
Acupuncture- Comprehensive Study by Type (Needle Acupuncture, Moxibustion Acupuncture, Cupping, Auricular, Others), End-User (Hospitals, Speciality clinics, Wellness Centre, Others), Needle Type (Non...
$ 3800
United States Non-Invasive Prenatal Testing Comprehensive Study by Type (High & Average Risk, Low Risk), Application (0-12 weeks, 13-24 weeks, 25-36 weeks), Consumables (Assay Kits & Reagents, Dispos...
$ 3800
Clinical Reference Laboratory Comprehensive Study by Type (Human & Tumor Genetics, Clinical Chemistry, Medical Microbiology & Cytology, Esoteric Tests), Application (Bioanalytical & Lab Chemistry Ser...
$ 3800
Imaging CRO Services Market Report Comprehensive Study by Technology (Decentralized and Remote Trials, Wearable Technology, Biostimulation, Others), Phase (Phase 0, Phase I, Phase II, Phase III, Pha...
$ 3800
Kidney Stone Comprehensive Study by Stone Type (Calcium Oxalate Stones, Uric Acid, Struvite Kidney Stones, Cystine Stones, Calcium Phosphate Stones), Treatment Type (Medications, Extracorporeal Shock...
$ 3800